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Abstract
Some Acanthamoeba species are distributed in natural and man-made environments, in a
wide range of soil and aquatic habitats, also in clinical settings. The amphizoic organisms
can exist as facultative parasites - causative agents of serious human disease, Acanthamoe‐
ba keratitis. The vision-threatening eye disease occurring particularly in contact lens
wearers is reported with increasing prevalence in different regions of the world. The
amoebic keratitis is difficult to diagnose as clinical symptoms are similar to those ob‐
served in other eye diseases. Moreover, bacterial, viral, fungal, and amoebic co-infections
frequently occur; also amoebae act as carriers for ~ 20 species pathogenic for humans, e.g.
from Pseudomonas, Legionella, Mycobacterium and Escherichia genera; thus the corneal dis‐
ease is frequently misdiagnosed. Complex etiology, late proper recognition of amoebic
infections, and the exceptional resistance of Acanthamoeba cysts to chemicals are impor‐
tant factors influencing diagnostic and therapeutic difficulties. Surgical interventions are
needed as an alternative treatment in refractory Acanthamoeba keratitis. It should be taken
into consideration that the knowledge and awareness of increasing threat generated by
the amphizoic amoebae are still insufficient. This compilation presents selected aspects of
eye disease that is becoming the increasingly significant for human health worldwide.
Keywords: Acanthamoeba keratitis, risk factors, symptoms, pathogenesis, diagnostics,
therapy
1. Introduction
Acanthamoeba keratitis (AK), the vision-threatening corneal disease that was first time recog‐
nized in 1973 in the United States in a Texas rancher [1], is reported with increasing prevalence
in different regions and countries year after year [1- 7]. This corneal, usually acute and
progressive infection is becoming increasingly significant for human health worldwide.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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Eye diseases affecting the cornea are a major cause of blindness worldwide. Among different
infectious agents, bacteria, fungi, viruses and protozoans may be causes of keratitis in contact
lens users. At present, the epidemiology of microbial keratitis is complicated, diverse, and even
controversial; the use of contact lenses is considered as the most important risk factor of corneal
infections in humans [4,8]. It was emphasized in several reviews [8- 10] that the incidence rates
of particular organisms causing keratitis associated with contact lens wear differ between parts
of the world, from country to country and even from one population to another. Economic
factors, various frequencies of contact lens wear in particular geographical locations, different
availabilities and standards of eye care, and different methods of etiological agent isolation
and culture in particular surveys were mentioned as factors influencing the differences and
criteria taken into consideration in the studies.
The frequency of microbial keratitis cases caused by Gram-negative bacteria from genus
Pseudomonas (as percent of total isolates from given location) varied in Europe: from 6.6% in
Turkey to 72.2% in Italy and from 12% to 28.5% in various surveys from the United Kingdom
[8]. Climate also influenced the incidence of bacterial keratitis: e.g.in Australia, the frequency
of P. aeruginosa contact lens keratitis was increased in tropical zones than temperate zones.
The highest proportion of fungal corneal infections (Aspergillus sp., Candida sp.), 67% was
found in India [9]; in Europe, the highest frequency of 22.2% was found in Turkey.
Correlations between the contact lens wear and percentages of bacterial and fungal keratitis
were statistically significant.
The viruses from Herpes spp. are other agents of keratitis. There are relatively few studies on
the epidemiology of Herpes keratitis in humans. According to review by Farooq and Shukla [11],
in developed countries, Herpes keratitis is believed to be an important cause of infectious
blindness mainly resulting from stromal opacification, e.g. it was reported from France that the
incidence was 25.8 (21.2–30.4) per 100,000 person-years; 95% of the cases occurred in contact
lens users. These authors found that the incidence of this keratitis is about 1.5 million, includ‐
ing 40,000 new cases of severe visual impairment each year, however, it is difficult to ascer‐
tain the frequency of the viral keratitis because of a lack of surveillance-based epidemiologic
studies [11].
Protozoan eye disease, Acanthamoeba keratitis (AK), is rare in the general population (estimated
incidence: 1.4 per million person- year) but much frequent in contact lens wearers. [4,12,13].
In the United States, an estimated 85% of cases occur in contact lens users. The incidence of
the disease in developed countries is approximately 1-33 cases per million contact lens wearers,
e.g. in England 17-21 cases per million. Currently, it is emphasized that an awareness and
knowledge about AK -the serious, vision-threatening eye disease are still insufficient [12,18].
Previous and recent studies continued in many centers with a participation of practicing
researchers and other scientists are crucial for a better understanding of Acanthamoeba keratitis
[4,14-18]. Advances in the field are expected by both laboratory and clinical practitioners;
particularly, an improvement in duration from first symptoms until suitable diagnosis as well
as in efficacy of the therapeutic management and prophylaxis is the urgent need. Here, we
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present selected aspects of this multi-factorial human disease, including the results of our
studies and own experiences in the topic.
1.1. Possible environmental sources of Acanthamoeba spp.
Free-living amoebae belonging to Acanthamoeba genus are ubiquitous and widely distributed
in natural and man-made environments of many parts of the world [4,19-25]. The amoebae
have been isolated from a wide range of soil and aquatic habitats; they occur in sea, fresh-
chlorinated- and tap- water, drinking water systems, bottled mineral water, thermal recrea‐
tional waters, swimming pools, air, air-conditioning systems including humidifiers, soil and
dust, and sewage. The amoeboid protists have been found in fruits, vegetables, and also
healthy, diseased or dead animals [12,18]. The amoebae have been isolated also from clinical
settings and the hospital environment: on surfaces of different equipment and accessories, in
water and air-conditioning systems, on surgical instruments, in dental irrigation units, in
contact lenses and their cases, and in dialyzers [7,26,27].
1.2. The developmental forms and classification of Acanthamoeba spp.
The amoeboid, mitochondria-bearing protist is known as free-living organism that exists in
two morphologic forms: trophozoite and cyst [4,12,18]. The life cycle of Acanthamoeba is
asexual; the reproduction of trophozoite is by binary fission. This active vegetative stage
contains one nucleus with large, central nucleolus (endosome), ectoplasm and granular
endoplasm, with a large contractile vacuole as well as numerous mitochondria and digestive
vacuoles. The trophozoite is changing in shape, 15–45µm in size and moving by cytoplasmic-
transparent pseudopodia that create characteristic protrusions: spine-like acanthopodia. The
dormant stage, cyst is smaller, 8-24µm in size, rounded or polygonal in shape, and double -
walled, with wrinkled or rippled outer layer; the form indicates minimal metabolic activity.
The outer wall of the cyst, the so-called ectocyst, contains lipids and proteins; the inner cyst
wall, endocyst contains cellulose that is not present in trophozoite stage. The two cyst walls
are separated by a space, except of points in that both walls meet; in these points - pores, i.e.
ostioles occur that are covered by plugs, so-called opercula. The plugs are removed when
trophozoites emerge from cysts during excystation [4,12]. Trophozoites transform into cyst
stages after the growth developmental phase of amoeba population, in which high cell density
occurs as well as under harmful environmental conditions (e.g. extremes in temperature and
pH, increased or decreased osmolarity, lack of nutrients). The therapeutic experience and
many in vitro studies showed that the cysts are highly resistant to antimicrobial drugs and a
variety of chemical and physical agents [reviewed in 4,12]; they can remain viable under
prolonged desiccation, starvation, heat and cold. Also, they can survive in vitro in distilled
water as long as 25 years [28] and maintain their viability and virulence.
Following the recognition of the amoebae and increasing number of isolates belonging to the
genus Acanthamoeba, for years they were classified using morphological criteria. In this
classification, a size of cysts and the number of characteristic arm -like structures visible within
a single cyst in light microscope were mainly taken into consideration [4,12,18,29,30]. At the
time, 18 species have been determined and placed in three morphological groups I, II and III.
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The classification of Acanthamoeba species /isolates changed with the advances in molecular
methods. Recently, it is based on genotype associations - the 18S rRNA gene sequence
[5,20,31-33]. The modern approach differs from morphology solely: the species identification
is based on combination of the morphological and molecular characterization [3,5,15,20]. At
present, 18 or19 genotypes are distinguished for diagnostics and for the characterization of
clinical and environmental Acanthamoeba isolates [12,15,18,31-33].
2. Acanthamoeba spp. as potential agents of human diseases
The protozoans belonging to Acanthamoeba spp. complete their life cycles in different outer
environments as free-living organisms. Trophozoite forms are able to feed on various micro‐
organisms dwelling in soil and water (on bacteria, algae, and yeasts as well as on other
protozoans) and on small organic particles. In natural, and even in man-made environments,
the amoebae develop without entering human or animal organisms. However, in predisposing
circumstances, the amoebae may enter the human body. According to literature [34,35], there
are evidences from various regions that humans are exposed frequently to the amoebae: it has
been confirmed by 50–100% of the healthy populations having specific anti- Acanthamoeba
antibodies. The protists may permeate into the human body without pathogenic consequences.
Investigations in which serological, biochemical and molecular methods were applied showed
that people may be exposed both, to pathogenic as well as non-pathogenic Acanthamoeba strains
[reviewed in 12,13,18]. In immunocompetent individuals, infections with these amoebae may
be asymptomatic and/or self-limited.
Nevertheless, several amoebic strains belonging to this genus are able to enter, and colonize
human organs and multiply within them, indicating pathogenic effects [4,12,26,27,36].
                                                 
Figure 1. Acanthamoeba sp. - wet-mount slides from corneal scrapings; note characteristic spine-like acanthopodia in
trophozoites and the double-walled cysts; light micrographs; scale bar = 10µm
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For this reason, these amoebae are called amphizoic amoebae, because they are able to exist in
two different modes: as free-living-exozoic organisms and as endozoic parasitic organisms,
within host tissues; thus, the free-living protozoans are also believed as facultative parasites.
Trophozoites and cysts of Acanthamoeba were detected during infections of various human
cavities and tissues: in paranasal sinuses in rhino-sinusitis, in skin inflammation and skin
ulceration, and in pneumonia [7,37,38]. We also found trophozoites and numerous cysts of
Acanthamoeba among the oral cavity microbiota in 4% somatically and mentally disordered
patients. The amoebae accompanied infections with other amoebae, Entamoeba gingivalis, the
oral amoebae associated with a prolonged deterioration of the periodontium and gingiva [39].
Developmental stages of the amphizoic species may be causative agents of an systemic
opportunistic disease developing in immunocompromised individuals. This is rare but almost
always fatal granulomatous Acanthamoeba encephalitis (GAE) [6,12,18,40]. Other infection
caused by the amphizoic amoebae may result in a sight-threatening Acanthamoeba keratitis
(AK), a non-opportunistic disease occurring mainly in immunocompetent persons, mostly in
contact lens wearers [1-3,7,14].
3. Pathogenesis in AK
In the early phase of AK, there are nonspecific symptoms variable in their intensity starting
with redness, photophobia, and excessive tearing. Most commonly, only one eye is involved.
Active epithelial inflammations usually progress from the outermost layer of the cornea
deeper, to the stroma. Symptoms of the devastating eye disease include loss of the visual acuity.
In many cases of AK, excruciating eye pain occurs, in which the intensity is often incommen‐
surate with relatively small degree of corneal deterioration. There are clinical and histopatho‐
logical evidences that the severe pain is associated with Acanthamoeba trophozoite activeness
that result in the inflammation of the corneal nerves -radial keratoneuritis [4,27]. It is also
emphasized that a characteristic ring-like corneal infiltration may occur in some patients. This
amoebic eye infection may develop from a few days to several months, as a severe, prolonged
disease, which, without suitable treatment may lead to blindness.
A pathogenesis of Acanthamoeba keratitis is a multi-factorial process connected with some
factors contributing directly and indirectly in production of diseases in humans [12].
Among the direct contributing factors, the following are listed: adhesion of Acanthamoeba
trophozoites to host cells, phagocytosis to take up food particles, neuraminidase activity, and
secretion of toxins. The neuraminidase enzyme, which is active at 25-30 ºC, is believed to be
important in a damaging of corneal epithelial cells [12,41]. Recently, the first toxin, acantha‐
porin, with pore-forming activity, cytotoxic for human neuronal cells was isolated from
Acanthamoeba, which activation mechanism remains under investigations [12,42].
Among the indirectly contributing factors, there are amoebic and host determinants. Morpho-
physiological features: the amoeboid motion and spine-like acanthopodia allow protozoans
to modulate binding to biological and inert surfaces. Also, changes in the overall numbers of
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the amoebae as well as in the proportion of trophozoites and cysts dependent on the environ‐
mental conditions are also listed as the amoebic pathogenesis determinants. The temperature
tolerance, osmotolerance and growth at different pH allow the amphizoic Acanthamoeba to exist
in different environments and simultaneously easy adapt to different human organ and
tissues, including the human cornea. Moreover, it has been shown that both, clinical and
environmental Acanthamoeba strains/isolates vary in their among the oral cavity microbiota
pathogenicity. The thermal tolerance and ability to grow at high temperature are considered
to be indirect markers of the pathogenicity of Acanthamoeba strains [12,17,18,43-45].
4. Predisposing/ risk factors sufficient to contract AK
In several studies it is underlined that the initiating of AK is a multi-factorial process, in which
both host and environmental determinants are likely involved, apart connected with Acantha‐
moeba pathogenic strains [4,12].
It is considered that Acanthamoeba keratitis is mainly related to contact lens wear, although,
Acanthamoeba corneal infections are also detected in persons not using contact lenses [7,12-14,
46]. After the first case of AK associated with contact lenses in Central Europe was reported
from Germany, more than 85% of all incidences of the disease have been recognized in different
countries in wearers of contact lenses [12,17,18,47-50].
The estimation of AK findings in several countries showed various, generally relatively low,
but constantly increasing number of the cornel disease incidents during the last few decades
i.e. 1.36 cases per million contact lens wears in the United States, 17 to 21 cases per million in
England, 1 per 30,000 contact lens wears in France, 0.05 per 10,000 in Holland [4,12,13].
However, “it is noteworthy”, as Khan [4] concluded “that variations in the incidence rate of
Acanthamoeba keratitis do not reflect the geographical distribution of Acanthamoeba, and are
most likely due to variations in the extended wear of soft contact lenses, varied awareness of
the potential risk associated with the contact lens wear, enhanced detection, and/or local
conditions that promote growth of pathogenic Acanthamoeba only e.g.. water hardness or
salinity, or conditions that suppress growth of non-pathogenic Acanthamoeba.” Interestingly,
in Austria, women and men were affected almost equally; the highest AK incidences occurred
in the 21-30-years-old patients; simultaneously, poor contact lens hygiene is indicated as the
most important risk factor of AK in this country [46].
Some micro-traumas occurring earlier or appearing in connection with the use of the lenses
predispose to contract AK; a human organism’s susceptibility, tissue specificity, tear factors,
and secretory immunoglobulin A (sIgA), important in the specific immune defense mecha‐
nism, are among other host factors influencing development of this corneal disease. Environ‐
mental conditions such as temperature, osmolarity, and pH may be important in initiating AK.
Simultaneously, the amoebae were found in contact lens and in storage cases that may be
potential sources and reservoirs of the facultative parasites [12,18,47-53]. In spite of this, the
incidence rate of AK in wearers of contact lenses is remarkably low in comparison with the
contact lens storage cases contaminated with Acanthamoeba.
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Additionally, it has been confirmed for various Acanthamoeba strains that a swimming in
recreational pools while contact lenses wearing promotes the infection; it is because of some
human corneal micro-defects caused by lenses and extremely high resistance of the amoebae
to chlorine disinfectants [12,17, 49-53].
In persons not using contact lenses, other circumstances influence as important for contract
AK [4,47]. The different Acanthamoeba strains are ubiquitous in natural and man-made
environments thus, an exposure of the eye especially to dust, water or moist soil, as well as to
any foreign particle, on which trophozoites and cyst of the amoebae can occur, is considered
as an AK predisposing factor. Also, if corneal epithelial injuries appear, and also during eye
surgery, circumstances promoting the infection may occur.
There have been no reports of Acanthamoeba keratitis being spread from one person to another.
5. When the clinician should suspect Acanthamoeba keratitis?
It is known, that the emerging vision-threatening AK is difficult to diagnose because clinical
manifestations are similar to those observed in the course of other infectious eye diseases.
In anamnesis, in the early stage of this eye disease - patients are complaining of photophobia,
excessive tearing, and reduced visual acuity; the clinical manifestations of this keratitis may
also include redness and eyelid edema [13,17,50,54].
Particularly, if a presence of any foreign particles will be excluded, appearing of excruciating
eye pain with intensity incommensurate with degree of corneal deterioration may suggest that
Acanthamoeba infection develops; however, the pain not always occurs. As a rule, AK should
be suspected if, in anamnesis, the contact lens wear, a history of swimming in a lake, and in
recreational pools while contact lenses wearing, exposure to soil, any case of corneal trauma,
surgical procedures are reported to clinician [12,18]. However, according to different reports
and own experience, the amoebic etiology of the keratitis cannot be excluded in patients with
above mentioned symptoms and history, previously unsuccessfully treated in ophthalmic
units with antiviral, antibacterial and/or antifungal medications that delayed proper diagnosis
and the suitable therapeutic management [17,50,55].
6. Differential diagnosis of AK
6.1. A tentative diagnosis of AK
The non-invasive methods are useful for the tentative diagnosis of AK, in which the slit-lamp
that provides magnification from 10 to 25 times and in vivo confocal microscopy (Figures 2 and
3) are applied [4,12,44,50,56].
The use of a slit lamp is indicated in any acute situation that requires magnification to inspect
the anterior segment of the eye. Active epithelial inflammations and hyper reflective tissues
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in the affected eye may be visualized by the slit lamp; a corneal ulcer and characteristic, ring-
like corneal infiltration may occur in some patients. However it should be underlined that the
characteristic ring infiltrate is seen in approximately 50% of AK cases.
Figure 2. Slit-lamp photograph of corneal ulceration of severe Acanthamoeba keratitis case.
Figure 3. Hyper reflective objects - Acanthamoeba cysts in the affected eye with the late diagnosed severe keratitis; in
vivo confocal microscopy; scale bar = 50µm
Different clinical presentations may occur in various causes of keratitis. However, in clinical
AK practice there are nonspecific signs variable in their intensity starting with photophobia,
redness, and excessive tearing that present with similar symptoms as viral, bacterial and fungal
keratitis (4,7, 9-12].
In the slit lamp, corneal epithelial disease caused by Herpes simplex virus may be seen as
dendritic keratitis or the geographic ulcer. The edges of these lesions with swollen epithelial
cell stain with rose bengal while the central part stains with fluorescein [11,12,18].
Bacterial corneal infection appears typically as a one gray-white stromal infiltrate with well-
demarked borders. Critical sings for fungal keratitis, e.g. Fusarium keratitis, are stromal gray-
white or yellow-white infiltrate with a feathery border, satellite lesions surrounding the primary
lesion; co-infections with fungi and bacteria can complicate the fungal keratitis [9,10,12].
In the early epithelial stage of Acanthamoeba keratitis, this infection can be misdiagnosed as a
Herpes simplex keratitis because of irregular grayish lesions and pseudodendrites that are
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frequently observed in the epithelium. In advanced stage, AK can be mistaken as a fungal
keratitis [9,11,12].
Active epithelial inflammations usually progresses from the outermost layer of the cornea -a
superficial keratitis -to deeper stroma -the stromal or interstitial keratitis.
In the initial epithelial phase, typical signs of AK include epithelial or sub-epithelial infiltrates,
pseudodendrites resembling these observed in Herpes keratitis, radial keratoneuritis (infil‐
trates along corneal nerves) and recurrent puncture staining of the corneal epithelium.
Perineural infiltrates -a radial keratoneuritis are described as pathognomonic for the diagnosis
of Acanthamoeba keratitis [12,18]; they are evoked by tropism of the amoebic organism for
corneal nerves. Radial keratoneuritis is the reason for the extreme pain and is usually seen
during the first one to four weeks of disease. Anterior stromal infiltrates are another common
sing of AK. They gradually enlarge and coalesce to form a ring abscess, commonly located in
the center of the cornea. Less specific signs of AK are satellite stromal infiltrates, diffuse stromal
infiltrates and endothelial plaques observed in many of the patients.
Later signs of AK develop in 3-8 weeks and include a deep inflammation of the cornea
consisting of a central stromal thinning and melting, anterior chamber cells and flare, hypo‐
pyon and extension of inflammation into sclera. The latter is generally reactive reaction rather
than extension of infection; later in the disease course, the slowly progressive stromal opaci‐
fications and neovascularization may occur.
Etiological agents of infectious keratitis can be differing using in vivo confocal microscopy that
is confirmed as useful tool for rapid diagnosis with high sensitivity [4,12,18,56,57].
Common findings in viral keratitis are: highly reflective, desquamating epithelial cells in
superficial epithelial layer, multiple dendritic cells in basal epithelial layer, the absence of
subepithelial nerve plexus, and hyperreflective keratocytes in the anterior stroma.
In bacterial keratitis, confocal micrographs typically reveal leucocytes infiltrating the corneal
stroma and adherent to vessel walls. In some cases, the dendritic cells are present intrastro‐
mally; the bacteria themselves cannot be detected with the confocal microscopy.
Filamentous fungi and bacteria (e.g. Nocardia) can form filamentous structures that are large
enough to be distinguished by confocal microscopy [57]. Another characteristics sing of
filamentous fungal infection is hyphae branching, in a case of Aspergillus at 45o and in a case
of Fusarium at 90o.
The examination of affected eyes by in vivo confocal microscopy make possible to distinguish
AK from the aforementioned infectious keratitis. Lately, confocal scan features of cysts and
trophozoites as well as associated corneal epithelial and stromal findings were described as
criteria to specify AK in clinical diagnosis [57]. Presumable Acanthamoeba cysts can be visible
as numerous hyper reflective, double-walled ovoid or spherical objects, 10-25µm in diameter,
localized typically in deeper parts of epithelium and in anterior layers of the corneal stroma
[4,18,57]. These findings should be distinguished from the well-delineated individual epithe‐
lial cell nuclei or leucocytes; the latter are larger and more regular than Acanthamoeba cysts.
The outer wall of the cyst is more reflective than internal wall; with time, some cysts are not
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seen and the others become calcified. Trophozoites are also described as visible in confocal
scan images, however, false results can occur because the forms are difficult to distinguish
from nuclei of leukocytes and keratocytes [4,12,18]. Although confocal microscopy, if available,
is non-invasive, high- sensitive tool for rapid in vivo diagnosis, examiners have to be familiar
with morphology of Acanthamoeba forms. Also, differences in strain pathogenicity and viability
can be taken into consideration.
It was evident also in our studies on monitoring of in vitro dynamics of Acanthamoeba strains
isolated from infected eyes [17,50]; the presence of hyper reflective objects/cysts was revealed
by this non-invasive in vivo confocal microscopy mainly for severe, late diagnosed infections
with strains of which strong viability was indicated by intensive multiplying of trophozoites
in vitro and their long survival time (42 months) in culture medium. Contrary to this, no cysts
were detected by the confocal technique in material from corneal scraping if infections with
weak viability strains occurred; a low amoeba number in the exponential growth phase and
short (10 days) survival time of such amoeba strains were manifested in vitro in the culture
medium. Also, no cyst was found in confocal microscopy images when mixed infections
occurred, although finally the infection with Acanthamoeba was confirmed by laboratory
methods.
Negative results of the in vivo confocal microscopy were reported if patients have already been
pre-treated, thus the amoeba density was very low [12,50].
6.2. Why clinical manifestations are not sufficient to indicate a causative agent of keratitis
Knowledge and awareness of threat are necessary as the most important step in proper AK
diagnosis as it is underlined by J. Lorenzo-Morales et al. [12].
The careful anamnesis is very important and helpful. Most of the clinical symptoms of
Acanthamoeba keratitis are nonspecific and frequently a variability in their intensity is observed
and reported from different world regions. AK is often misdiagnosed as viral infection with
Herpes simplex, bacterial with Pseudomonas aeruginosa or keratitis caused by fungi of genera
Fusarium or Candida; moreover, bacterial, viral, and fungal co-infections with Acanthamoeba
may occur [2,4,46]. This is why the clinical symptoms alone, as non- pathognomonic, are not
sufficient to indicate an etiological agent of human keratitis.
Undoubtedly, the non-invasive in vivo confocal microscopy is a valuable technique, however
usefulness of it is limited if bacterial or viral keratitis occurs, thus it should be applied for the
tentative diagnosis.
Also, in our several studies we analyzed serious keratitis cases regarding patients who were
under suspicion of Acanthamoeba etiology of the infections. Although, in our hospital, finally
AK was determined, there were mistakes in results of earlier diagnostics. The mixed amoebic,
bacterial (P. aeruginosa, E. faecalis), and fungal (Candida sp.) infections have been revealed by
us in more than 50% cases regarding persons previously unsuccessfully treated only with
antibacterial and antifungal medications in other ophthalmic units [17,50].
It has been reported that Acanthamoeba protozoans may carry more than 20 species pathogenic
for humans, among others bacteria belonging to genera Legionella, Pseudomonas, Mycobacterium,
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Listeria and Escherichia, protozoa Cryptosporidium sp., and fungi Cyrptococcus neoformans. The
microorganisms are able not only to survive within cells but even proliferate inside the
amoebae; thus, secondary infections can occur and influence diagnostic difficulties [4,12, 18].
6.3. Laboratory evaluation
Literature data as well as results of our studies indicated that microscopic visualization of
amoebae in unstained or stained slides prepared directly from corneal scraping is usefulness
for AK diagnostics. Also, laboratory examinations of specimens from in vitro cultivated corneal















Figure 4. Live Acanthamoeba trophozoites and cysts in unstained preparations from corneal isolates cultured in vitro;
light micrographs. Scale bars = 10µm
Moreover, culture methods are considered as the gold standard of diagnosis, which needs,
however, collaboration between clinicians and laboratory staff and, also, the familiarization
with a morphological characteristic of Acanthamoeba stages [12,14,18,55,58-60]. Non-nutrient
(NN) agar plates seeded with Gram- negative, non-mucous bacteria: Escherichia coli or
Enterobacter aerogenes are applied for isolation/growth of Acanthamoeba trophozoites both from
environmental and clinical samples (corneal scrapings, biopsies, swabs). The incubation of the
plates at 30ºC promotes a transformation of amoeba trophozoites into cysts within approxi‐
mately 1 week. Also, the cultivation of amoebae in bacteria-free (axenic) conditions in a
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modified enriched culture medium containing antibiotics (penicillin, streptomycin) is useful
for classification cysts to the morphological level.
Simultaneously, molecular methods of classification of Acanthamoeba isolates, with the use of
sensitive PCR techniques, basing on genotype associations are distinguishing for diagnostics
and for the characterization of clinical and environmental Acanthamoeba isolate
[12,18,27,32,33,59]. In this modern approach, the species identification is based on the combi‐
nation of morphological and molecular characteristics of amoebae. Additionally, our experi‐
ences gave convincing evidences of an importance of a clinical examination of the affected eyes
and laboratory differentiations/identification of amoebic forms in material deriving from
infected corneas.
7. Treatment options in AK
7.1. Factors complicating effective pharmacotherapy in AK
AK treatment is difficult and often unsuccessful despite of advances in pharmacotherapy.
There are several factors that are listed as influencing difficulties and still not fully effective of
applied therapy [12,18].
AK is often incorrect diagnosed due to nonspecific clinical symptoms; similar clinical pictures
to this observed in the amoebic keratitis may give a wide range of agents e.g. viral Herpes
simplex, bacterial -mostly Pseudomonas aeruginosa or fungi of Fusarium spp.
Additionally, mixed amoebic, fungal viral and bacterial keratitis may occur that complicate
therapeutic management.
Acanthamoeba strains vary in their pathogenicity: they may be virulent, weakly virulent or non-
virulent; they show different susceptibilities to chemicals and answer to pharmacotherapy.
It is also underlined that extremely high resistance of Acanthamoeba cysts to different chemicals,
disinfectants as well as anti-microbial and anti-parasitic drugs result in disappointing thera‐
peutic management [12,18,54,59-64].
Among the abovementioned facts, diagnostic mistakes that cause delayed in a beginning of
an efficient treatment may result in a prolonged, severe course of AK and vision deterioration.
It is also emphasized that some chemicals can induce amoebic encystment that subsequently,
by excystment, may lead to repeated development of trophozoites, thus an activation of the
dormant cysts can lead to recurrence of the disease. It is why not only amoebicidal effects but
also the cysticidal efficacy of applied therapeutics is very important [43-46].
In some research works, also in our experimental studies it has been reported that higher
concentrations of drugs and some new-synthesized imidazole derivatives may be in vitro
efficacious against Acanthamoeba strains and result not only in amoebostatic but also in
amoebicidal effects. However, many of these chemicals cannot be applied in vivo in such
concentrations due to their toxicity for human tissues [44-50].
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7.2. Treatment recommended in management in AK
Currently, there are not known single-treatment methods effective against both trophozoites
and cysts of Acanthamoeba; generally, AK is difficult to treat. Acanthamoeba stages differ in their
susceptibility to various drugs. Trophozoite form is highly responsive to the treatment, while
cysts are highly resistant as the cystic form protects the amoebic organism from unfavorable
environmental factors, including drugs. The therapeutic approach recommended in AK
consists of antimicrobial agent’s combination [4,12,18,36].
The mainstay agents that are used as a first-line treatment for Acanthamoeba keratitis are
diamidines (propamidine, hexamidine) and biguanides (polyhexamethylene biguanide (–
PHMB), chlorhexidine), which were found to be cysticidal anti-amoebics in vitro. PHMB is the
most preferred agent in monotherapy or in combinations with other drugs. Chlorhexidine can
also be used in monotherapy, but it is much more effective in combined treatment. Propami‐
dine is used in combination with one of biguanides, as the latter are more effective against
cysts of Acanthamoeba [65]. Although neomycin was used widely, it is ineffective against cysts
in vitro; thus, it is no longer used by most ophthalmologists.
However, particularly after earlier improper treatment in other centers, the combination drug
therapy with the antimicrobial agents is used more or less successfully. Additionally, such
factors as human organism status, a virulence of amoeba strains, phase of infection, and kind
and concentration of the chemicals applied may determine variability in effects of drugs on
trophozoites and cysts of several Acanthamoeba strains [12,16,22,45,50,64-67].
The most frequently used agents that achieve sufficient high concentrations at the site of
infection and are effective against trophozoites and cysts of Acanthamoeba are cationic disin‐
fectants: chlorhexidine 0.02–0.2% (200–2000 g/ml), polyhexamethylene biguanide (PHMB)
0.02–0.06% (200–600g/ml), and propamidine isethionate (Brolene 0.1%). These topical antimi‐
crobials should be administered immediately to the infected eye one to two drops on the
surface of the cornea at the first several days, every hour, minimum nine times/day, and, next,
every 3h. The therapy duration is depending on clinical response. The amoebae may persist
in the encysted stage for months and reactivate after therapy discontinuation. It was indicated
in many earlier and current studies that a therapy continuation is very important to avoid an
activation of the dormant cysts that may lead to repeated trophozoite development and thus
to recurrence of the disease [4,12,13]. Some authors advise the treatment for 3- 4 months in
order to preclude recurrence; however, the treatment for 6–12 months is also recommended.
Nevertheless, it is reported that Acanthamoeba strains/cysts resistance to drug may occur, which
is the main difficulty in AK treating [12,18,43,63,66]; particularly, resistance to propamidine
and, also toxicity effect are observed in the course of AK. Corneal epithelial toxicity has been
minimal for both chlorhexidine 0.02% and PHMB 0.02%. The greatest frequency of ocular
toxicity has been reported with propamidine; the most common side effect is the superficial
punctate keratopathy [65]. Pain can be relieved by topical cycloplegics (e.g. atropine 0.5-1.0%,
scopolamine 0.25% t.i.d.), agents and oral non-steroidal anti-inflammatory medications (e.g.
naproxen 250-500mg p.o. b.i.d.).
It should be also taken into consideration that co-infections with other microorganisms may
complicate the course and treatment of the severe amoebic disease [18,49-51].
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Although the low doses of topical steroids can be useful to diminish inflammation in cases of
controlled infection but the use of topical corticosteroids is controversial.
Systemic corticosteroids are preferred over topical ones in cases of severe inflammation. This
route of administration provides better ocular safety profile (less concentration in the cornea)
but less body safety profile. However there are some suggestions that steroid use may result
in increased pathogenicity of the amoebae [68].
If the topical pharmacotherapy fails, surgical interventions are needed [12,44,64,67]. Cross-
linking and cryopreserved amniotic membrane graft (AMG) have been reported to be effective
in AK.
The corneal transplantation can be performed for therapeutic or optical indications. Thera‐
peutic, usually penetrating, keratoplasty is applied when the infectious process spreads to the
corneal stroma, causing corneal melting and thinning despite of aggressive prolonged anti-
amoebic therapy [4,12,18]. In a case of threatening or completed perforation of the cornea, the
surgery must be performed urgently. Some authors recommend systemic steroids prior to
surgery if concomitant limbitis or scleritis is present [69].
Sacher et al.[70] show that pretreatment of Acanthamoeba keratitis with intravenous pentami‐
dine before therapeutic keratoplasty may assist with the achievement of microbiological cure,
clear graft, and good visual outcome in a majority of eyes with AK.
The size of corneal graft should be minimum to excise an inflamed and necrotic tissue.
Although remaining clinically healthy cornea is frequently also infected, this tissue should be
saved because of the higher risk of rejection with large/decentrated grafts and because the
possibility of repeat grafting should be kept in mind in the event of recurrence; a further graft
represents a new food source for the organism and can be used to attract residual amoebae [69].
In a case of therapeutic keratoplasty for AK, the topical steroids in combination with anti-
amoebic drugs are applied for 6-12 months following keratoplasty, to relieve pain, lessen the
inflammation, and prevent graft rejection and recurrence of infection. Corneal grafts per‐
formed in the eyes with active inflammation are the high-risk transplants and they required
systemic immunosuppression similar to this given in organ transplants (cyclosporine and/or
mycophenolate mofetil). Apart from a poor graft survival, the postoperative glaucoma is a
frequent complication.
In optical keratoplasty performed after resolution of active keratitis there is an excellent
prognosis for both graft survival and visual outcome [71].
Promising clinical results were reported from amoebicidal effect of combined riboflavin and
UV-A (ultraviolet light A, 365nm wavelength) exposure -corneal cross-linking (CXL) that was
used for stabilization of corneal melting which can delay surgical treatment [12,72,73]. CXL
has also an antimicrobial effect that is due to the effect of UV light interacting with riboflavin
as the chromophore. It damages both the DNA and RNA of pathogens. Photoactivated
chromophore for infectious keratitis (PACK)-CXL is an alternative to standard antibiotic
therapy in treating infectious corneal disorders, and may help reduce the microbial resistance
to antibiotics and avoid therapeutic keratoplasty in some cases [74].
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Many chemicals and antimicrobials were examined and are still tested in vitro for their
potential activity against different species, strains and isolates of Acanthamoeba [45,54,61-63,67].
Due to the toxicity of high concentrations of agents tested and a drug resistance, an optimal
strategy for anti-acanthamoebic treatment is not yet defined. Further studies in this field are
needed, particularly, in terms of cysticidal effects of the chemicals tested.
8. Prevention and prognosis of AK
The Acanthamoeba species are ubiquitous and widely distributed in natural and man-made
environments. In various regions, humans were exposed frequently to the amoebae, that has
been confirmed when in healthy populations specific anti- Acanthamoeba antibodies have been
detected. For this reason, knowledge and awareness of threat are important to avoid the
infection [6,12,18].
The contact lens wearers must be well educated as for the proper use and care of their lenses;
do not use saline solution for lens storage, and do not to swim wearing contact lenses or use
the swimming goggles. It is also very important to educate the ophthalmologist to be aware
of signs and symptoms of AK and be able to early diagnose and initiate suitable treatment.
The prognosis for visual recovery with only mild residual stromal involvement is very good;
in other cases, the visual prognosis is poor. Generally, a prediction depends on inflammation
status at the time of diagnosis and the prompt initiation of proper treatment.
A retrospective review indicates that early diagnosis (less than 18 days) results in better final
visual acuity and less likely needs keratoplasty [75]. In the early stage of infection, trophozoite
forms are predominated, and the infection is confined to the superficial corneal layers. With
time as the process progresses, the microorganisms enter to the deeper corneal stroma and
encyst. Cysts are much more resistant to anti-protozoan drugs compared to trophozoites.
Severe inflammation, scleral involvement, late diagnosis, and retardation of the therapy
initialization are associated with poor clinical outcomes. In 10% of cases, there is associated
scleritis. Acanthamoeba sclerokeratitis is associated with poor clinical outcomes [12,13,75].
9. Conclusions
Complex infective etiology and late recognition of amoebic infections were the important
factors influencing diagnostic and therapeutic difficulties in AK. Laboratory examinations
including in vitro cultivation of the isolates, acquired from corneal scrapings, allow directly to
identify the facultative pathogens -the causative agents of the keratitis and to verify previous
misdiagnoses. Early proper diagnosis in Acanthamoeba keratitis, confirmed by detection of live
trophozoites in corneal scraping cultures are decisive for the treatment efficacy, particularly
in contact lens wearers. The pharmacotherapy of the infectious eye disease is often unsuccess‐
ful; among others, it is if chemicals induce amoebic encystment; subsequently, an activation
of the cysts can lead to repeated development of trophozoites and recurrence of the disease.
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In some severe cases, keratoplasty and prolonged application of a mixture of drugs may be an
appropriate option for visual rehabilitation.
Moreover, as our studies and experience show, in vitro monitoring of dynamics of Acantha‐
moeba strains isolated from affected eyes may be useful tool for proper diagnosis, therapeutic
management and treatment prognosis.
Human infections with facultative parasitic Acanthamoeba strains are serious medical problem
that should be taken into consideration as emerging threats of the public health worldwide.
Therefore, further educational efforts directed first of all to contact lens users are desirable for
the prevention of this vision-threatening corneal disease.
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